Cargando…
The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
BACKGROUND: Previous studies found the dysbiosis of intestinal microbiota in diabetic kidney disease (DKD), especially the decreased SCFA‐producing bacteria. We aimed to investigate the concentration of the stool and serum short‐chain fatty acids (SCFAs), gut microbiota‐derived metabolites, in indiv...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649351/ https://www.ncbi.nlm.nih.gov/pubmed/34689373 http://dx.doi.org/10.1002/jcla.24062 |
_version_ | 1784610978744238080 |
---|---|
author | Zhong, Chenyu Dai, Zhiwei Chai, Lingxiong Wu, Lingping Li, Jianhui Guo, Weiying Zhang, Jie Zhang, Qun Xue, Congping Lin, Haixue Luo, Qun Cai, Kedan |
author_facet | Zhong, Chenyu Dai, Zhiwei Chai, Lingxiong Wu, Lingping Li, Jianhui Guo, Weiying Zhang, Jie Zhang, Qun Xue, Congping Lin, Haixue Luo, Qun Cai, Kedan |
author_sort | Zhong, Chenyu |
collection | PubMed |
description | BACKGROUND: Previous studies found the dysbiosis of intestinal microbiota in diabetic kidney disease (DKD), especially the decreased SCFA‐producing bacteria. We aimed to investigate the concentration of the stool and serum short‐chain fatty acids (SCFAs), gut microbiota‐derived metabolites, in individuals with DKD and reveal the correlations between SCFAs and renal function. METHODS: A total of 30 participants with DKD, 30 participants with type 2 diabetes mellitus (DM), and 30 normal controls (NC) in HwaMei Hospital were recruited from 1/1/2018 to 12/31/2019. Participants with DKD were divided into low estimated glomerular filtration rate (eGFR)(eGFR<60ml/min, n=14) and high eGFR (eGFR≥60ml/min, n=16) subgroups. Stool and serum were measured for SCFAs with gas chromatograph‐mass spectrometry. RESULTS: The DKD group showed markedly lower levels of fecal acetate, propionate, and butyrate versus NC (p<0.001, p<0.001, p=0.018, respectively) [1027.32(784.21–1357.90)]vs[2064.59(1561.82–2637.44)]μg/g,[929.53(493.65–1344.26)]vs[1684.57(1110.54–2324.69)]μg/g,[851.39(409.57–1611.65)] vs[1440.74(1004.15–2594.73)]μg/g, respectively, and the lowest fecal total SCFAs concentration among the groups. DKD group also had a lower serum caproate concentration than that with diabetes (p=0.020)[0.57(0.47–0.61)]vs[0.65(0.53–0.79)]μmol/L. In the univariate regression analysis, fecal and serum acetate correlated with eGFR (OR=1.013, p=0.072; OR=1.017, p=0.032). The correlation between serum total SCFAs and eGFR showed statistical significance (OR=1.019, p=0.024) unadjusted and a borderline significance (OR=1.024, p=0.063) when adjusted for Hb and LDL. The decrease in serum acetate and total SCFAs were found of borderline significant difference in both subgroups (p=0.055, p=0.050). CONCLUSION: This study provides evidence that in individuals with DKD, serum and fecal SCFAs levels (fecal level in particular) were lowered, and there was a negative correlation between SCFAs and renal function. |
format | Online Article Text |
id | pubmed-8649351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86493512021-12-28 The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease Zhong, Chenyu Dai, Zhiwei Chai, Lingxiong Wu, Lingping Li, Jianhui Guo, Weiying Zhang, Jie Zhang, Qun Xue, Congping Lin, Haixue Luo, Qun Cai, Kedan J Clin Lab Anal Research Articles BACKGROUND: Previous studies found the dysbiosis of intestinal microbiota in diabetic kidney disease (DKD), especially the decreased SCFA‐producing bacteria. We aimed to investigate the concentration of the stool and serum short‐chain fatty acids (SCFAs), gut microbiota‐derived metabolites, in individuals with DKD and reveal the correlations between SCFAs and renal function. METHODS: A total of 30 participants with DKD, 30 participants with type 2 diabetes mellitus (DM), and 30 normal controls (NC) in HwaMei Hospital were recruited from 1/1/2018 to 12/31/2019. Participants with DKD were divided into low estimated glomerular filtration rate (eGFR)(eGFR<60ml/min, n=14) and high eGFR (eGFR≥60ml/min, n=16) subgroups. Stool and serum were measured for SCFAs with gas chromatograph‐mass spectrometry. RESULTS: The DKD group showed markedly lower levels of fecal acetate, propionate, and butyrate versus NC (p<0.001, p<0.001, p=0.018, respectively) [1027.32(784.21–1357.90)]vs[2064.59(1561.82–2637.44)]μg/g,[929.53(493.65–1344.26)]vs[1684.57(1110.54–2324.69)]μg/g,[851.39(409.57–1611.65)] vs[1440.74(1004.15–2594.73)]μg/g, respectively, and the lowest fecal total SCFAs concentration among the groups. DKD group also had a lower serum caproate concentration than that with diabetes (p=0.020)[0.57(0.47–0.61)]vs[0.65(0.53–0.79)]μmol/L. In the univariate regression analysis, fecal and serum acetate correlated with eGFR (OR=1.013, p=0.072; OR=1.017, p=0.032). The correlation between serum total SCFAs and eGFR showed statistical significance (OR=1.019, p=0.024) unadjusted and a borderline significance (OR=1.024, p=0.063) when adjusted for Hb and LDL. The decrease in serum acetate and total SCFAs were found of borderline significant difference in both subgroups (p=0.055, p=0.050). CONCLUSION: This study provides evidence that in individuals with DKD, serum and fecal SCFAs levels (fecal level in particular) were lowered, and there was a negative correlation between SCFAs and renal function. John Wiley and Sons Inc. 2021-10-24 /pmc/articles/PMC8649351/ /pubmed/34689373 http://dx.doi.org/10.1002/jcla.24062 Text en © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Zhong, Chenyu Dai, Zhiwei Chai, Lingxiong Wu, Lingping Li, Jianhui Guo, Weiying Zhang, Jie Zhang, Qun Xue, Congping Lin, Haixue Luo, Qun Cai, Kedan The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease |
title | The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease |
title_full | The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease |
title_fullStr | The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease |
title_full_unstemmed | The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease |
title_short | The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease |
title_sort | change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649351/ https://www.ncbi.nlm.nih.gov/pubmed/34689373 http://dx.doi.org/10.1002/jcla.24062 |
work_keys_str_mv | AT zhongchenyu thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT daizhiwei thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT chailingxiong thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT wulingping thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT lijianhui thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT guoweiying thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT zhangjie thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT zhangqun thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT xuecongping thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT linhaixue thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT luoqun thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT caikedan thechangeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT zhongchenyu changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT daizhiwei changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT chailingxiong changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT wulingping changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT lijianhui changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT guoweiying changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT zhangjie changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT zhangqun changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT xuecongping changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT linhaixue changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT luoqun changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease AT caikedan changeofgutmicrobiotaderivedshortchainfattyacidsindiabetickidneydisease |